Get started
Author

Nanaka Kaneshiro

Observed name: Kaneshiro, Nanaka
ORCID: 0000-0003-4452-2655
Observed ORCID: 0000-0003-4452-2655
OpenAlex ID: A5081921238
The Pursuit of the “Inside” of the Amyloid Hypothesis—Is C99 a Promising Therapeutic Target for Alzheimer’s Disease?
2023 · Nobumasa Takasugi, Masato Komai, et al. · Cells · 24
PDF
TMEM30A is a candidate interacting partner for the β-carboxyl-terminal fragment of amyloid-β precursor protein in endosomes
2018 · Nobumasa Takasugi, Runa Araya, et al. · PLoS ONE · 19
PDF
Lipid flippase dysfunction as a therapeutic target for endosomal anomalies in Alzheimer’s disease
2022 · Nanaka Kaneshiro, Masato Komai, et al. · iScience · 17
PDF
Nuclear SphK2/S1P signaling is a key regulator of ApoE production and Aβ uptake in astrocytes
2024 · Masato Komai, Yuka Noda, et al. · Journal of Lipid Research · 13
PDF
Functional analysis of juxta- and intra-membrane domains of murine APP by genome editing in Neuro2a cells
2018 · Nanaka Kaneshiro, Ryosuke Imaoka, et al. · Biochemical and Biophysical Research Communications · 4
Long live the RNAs: The guardians of neuronal longevity?
2024 · Lin Lin, Naoto Kubota, et al. · Molecular Cell · 2
PDF
Development of a screening methods for Alzheimer's disease therapeutic agents based on the traffic jam hypothesis
2022 · Nobumasa Takasugi, Nanaka Kaneshiro, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
The analysis for βCTF mediated vesicular traffic impairment in Alzheimer disease
2020 · Nobumasa Takasugi, Nanaka Kaneshiro, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
The analysis of APP-βCTF mediated vesicle traffic impairment
2017 · Nanaka Kaneshiro, Takashi Uehara, et al. · The Japanese Biochemical Society/The Molecular Biology Society of Japan
Works count: 10
Citation count: 79
H-index: 4
I10-index: 4
Year
Topic
Type